ArticleBJC reports2024

Real-world effectiveness of CDK 4/6 inhibitors in estrogen-positive metastatic breast cancer.

Mathilde Louise Gehrchen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.